Eugene

[email protected]

LATEST

Novo Nordisk, Bluebird Bio Partner to Develop Gene Therapies
By

By
Novo Nordisk and Bluebird Bio, a developer of gene therapies for severe genetic diseases and cancer, have entered into a three-year research collaboration to jointly develop in vivo genome-editing treatments…

GSK, AstraZeneca in Project for Continuous Direct Compression
By

By
The UK’s Centre for Process Innovation (CPI), the UK government’s process manufacturing arm of Catapult centers that are designed to encourage innovation, has begun work on a project to develop…

Alexion To Acquire Achillion Pharmaceuticals for $930 Million
By

By
Alexion Pharmaceuticals, a Boston, Massachusetts-based pharmaceutical company focused on rare diseases, has agreed to acquire Achillion Pharmaceuticals, a Blue Bell, Pennsylvania-based clinical-stage biopharmaceutical company focused on developing oral small-molecule Factor…

FDA OKs New Molecular Entities from Novartis, Eli Lilly; AstraZeneca’s Self-Admin Fasenra
By

By
Novartis, Eli Lilly respectively get FDA approval for wet-age macular degeneration and migraine drugs, and AstraZeneca gets approval for its asthma drug in a new product form, a prefilled auto-injector. …

UCB To Acquire Ra Pharmaceuticals for $2.1 Bn
By

By
UCB has agreed to acquire Ra Pharmaceuticals, a clinical-stage biopharmaceutical company focused on therapies for rare diseases, for a total transaction value of approximately $2.1 billion. Under the agreement, Ra…

GSK, Lyell Immunopharma Form Pact for Cancer Cell Therapies
By

By
GlaxoSmithKline (GSK) has formed a five-year collaboration with Lyell Immunopharma, a San Francisco-based adoptive cell therapy biotechnology company, to develop new technologies for cell therapies for treating solid tumors. The…

Sanofi Opens Continuous Biomfg Facility in Massachusetts; Opens New UK HQ
By

By
Sanofi has opened a new digital continuous biomanufacturing facility in Framingham, Massachusetts and separately a new site for its UK headquarters. The new facility is part of Sanofi’s cross-functional biologics…

J&J Comments on $8-Billion Verdict in Risperdal Litigation
By

By
A jury has issued a verdict to award punitive damages of $8 billion against Johnson & Johnson (J&J) relating to litigation involving Risperdal (risperidone), an antipsychotic drug used to treat…

Avid Bioservices, Gerresheimer, Novasep Expand; Alcami Launches Testing Service
By

By
The latest news from CDMOs, CMOs, and suppliers featuring news from Alcami, Avid Bioservices, Gerresheimer, and Novasep. Biologics Manufacturing Avid Bioservices Completes Process Development Lab Expansion Avid Bioservices, a contract…

Global Pharma Briefs: News from Asia and the US
By

By
A roundup of developments and latest news from China (Biocad, Shanghai Pharma), India (Aurobindo, Glenmark, Lupin), and the US (Astellas). China Russia’s Biocad, Shanghai Pharma Finalize Joint Venture Biocad, a…